Trademark: 97594393
Word
AFFIMED
Status Date
Tuesday, January 23, 2024
Registration Number
7283747
Registration Date
Tuesday, January 23, 2024
Filing Date
Friday, September 16, 2022
Published for Opposition
Tuesday, November 7, 2023
5 Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes, all used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations for medical or veterinary purposes and in the form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for medical or veterinary purposes and for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes
1 Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and scientific experimentation purposes, in particular for conducting experimental assays, all of the foregoing other than for medical or veterinary purposes
42 Scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of virology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design and engineering design, all in the field of antiinfectives; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research, and design in the nature of new product design, all in the field of neurodegenerative diseases; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals
The mark consists of the term "AFFIMED" with a stylized image of a cell inside of a circle to the left of the letter "A" and with two short lines extending from the lower right edge of the circle.
AFFI MED
Color is not claimed as a feature of the mark.
Jan 23, 2024
Notice Of Registration Confirmation Emailed
Jan 23, 2024
Registered-Principal Register
Jan 4, 2024
Assigned To Examiner
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2023
Published For Opposition
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2023
Teas Change Of Owner Address Received
Oct 2, 2023
Approved For Pub - Principal Register
Sep 15, 2023
Teas/Email Correspondence Entered
Sep 15, 2023
Correspondence Received In Law Office
Sep 15, 2023
Teas Response To Office Action Received
Jul 3, 2023
Notification Of Non-Final Action E-Mailed
Jul 3, 2023
Non-Final Action E-Mailed
Jul 3, 2023
Non-Final Action Written
Jun 28, 2023
Assigned To Examiner
Oct 4, 2022
Notice Of Design Search Code E-Mailed
Oct 3, 2022
New Application Office Supplied Data Entered
Sep 20, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
